We are on a mission to help you to create superior value and optimise healthcare worldwide.
We believe in "A world where the value of health technologies is fully realised"
In any given year, there is a $50 billion gap between analysts’ predicted sales for all new life science products launches and their actual sales. At Inbeeo, we believe that alongside scientific challenges, the root cause of this gap is the lack of careful planning for and demonstration of value. This is why we call it “the value gap”.
With our vision in mind, we have aligned our services and products to four key mission areas
All health technologies should be priced according to the value they bring to patients, healthcare systems and society. We have tools and methods to help you to solve that equation.
Even the best strategies will fail without proper execution. We partner with you to translate your asset value and pricing strategy into an operational reality.
We never compromise on doing the right thing for our team, partners and wider society
Yigit graduated from University College London (UCL) with a First-Class Bachelor’s Degree in Biomedical Sciences, as well as an MSc in Drug Discovery and Pharmaceutical Management (with Distinction). During his Master’s, Yigit delivered projects spanning the whole pharmaceutical value chain, such as developing a clinical strategy for a new indication of a marketed drug and evaluating the implications of this strategy from a regulatory and market access standpoint. In addition to his studies, Yigit undertook industry experience at Silicon Valley-based biotech start-up Cantabio, where he supported the commercial development of multiple pipeline projects for the treatment of cancer and neurodegenerative diseases. Yigit now looks to further develop his expertise in pharmaceutical commercialisation by delivering critical pricing strategies and market access solutions.